FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200156908> ?p ?o ?g. }

• W4200156908 endingPage "629.e7" @default.
• W4200156908 startingPage "619" @default.
• W4200156908 abstract "Background & AimsThe shift to redefine nonalcoholic fatty liver disease (NAFLD) as metabolic associated fatty liver disease (MAFLD) can profoundly affect patient care, health care professionals, and progress within the field. To date, there remains no consensus on the characterization of NAFLD vs MAFLD. Thus, this study sought to compare the differences between the natural history of NAFLD and MAFLD.MethodsMedline and Embase databases were searched to include articles on prevalence, risk factors, or outcomes of patients with MAFLD or NAFLD. Meta-analysis of proportions was conducted using the generalized linear mix model. Risk factors and outcomes were evaluated in conventional pairwise meta-analysis.ResultsTwenty-two articles involving 379,801 patients were included. Pooled prevalence of MAFLD was 39.22% (95% confidence interval [CI], 30.96%–48.15%) with the highest prevalence in Europe and Asia, followed by North America. The current MAFLD Definition only accounted for 81.59% (95% CI, 66.51%–90.82%) of NAFLD diagnoses. Patients had increased odds of being diagnosed with MAFLD compared with NAFLD (odds ratio, 1.37; 95% CI, 1.16–1.63; P < .001). Imaging modality resulted in a significantly higher odds of being diagnosed with MAFLD compared with NAFLD, but not biopsy. MAFLD was significantly associated with males, higher body mass index, hypertension, diabetes, lipids, transaminitis, and greater fibrosis scores compared with NAFLD.ConclusionsThere were stark differences in the prevalence and risk factors between MAFLD and NAFLD. However, in the use of the MAFLD Definition, a greater emphasis on the management of concomitant metabolic diseases and a collaborative effort is required to explore the complex pathophysiologic mechanisms underlying the disease. The shift to redefine nonalcoholic fatty liver disease (NAFLD) as metabolic associated fatty liver disease (MAFLD) can profoundly affect patient care, health care professionals, and progress within the field. To date, there remains no consensus on the characterization of NAFLD vs MAFLD. Thus, this study sought to compare the differences between the natural history of NAFLD and MAFLD. Medline and Embase databases were searched to include articles on prevalence, risk factors, or outcomes of patients with MAFLD or NAFLD. Meta-analysis of proportions was conducted using the generalized linear mix model. Risk factors and outcomes were evaluated in conventional pairwise meta-analysis. Twenty-two articles involving 379,801 patients were included. Pooled prevalence of MAFLD was 39.22% (95% confidence interval [CI], 30.96%–48.15%) with the highest prevalence in Europe and Asia, followed by North America. The current MAFLD Definition only accounted for 81.59% (95% CI, 66.51%–90.82%) of NAFLD diagnoses. Patients had increased odds of being diagnosed with MAFLD compared with NAFLD (odds ratio, 1.37; 95% CI, 1.16–1.63; P < .001). Imaging modality resulted in a significantly higher odds of being diagnosed with MAFLD compared with NAFLD, but not biopsy. MAFLD was significantly associated with males, higher body mass index, hypertension, diabetes, lipids, transaminitis, and greater fibrosis scores compared with NAFLD. There were stark differences in the prevalence and risk factors between MAFLD and NAFLD. However, in the use of the MAFLD Definition, a greater emphasis on the management of concomitant metabolic diseases and a collaborative effort is required to explore the complex pathophysiologic mechanisms underlying the disease." @default.
• W4200156908 created "2021-12-31" @default.
• W4200156908 creator A5003334120 @default.
• W4200156908 creator A5004639766 @default.
• W4200156908 creator A5007912393 @default.
• W4200156908 creator A5009193858 @default.
• W4200156908 creator A5009462555 @default.
• W4200156908 creator A5015041967 @default.
• W4200156908 creator A5018422629 @default.
• W4200156908 creator A5023187572 @default.
• W4200156908 creator A5025459684 @default.
• W4200156908 creator A5033842737 @default.
• W4200156908 creator A5043846829 @default.
• W4200156908 creator A5044089244 @default.
• W4200156908 creator A5058087480 @default.
• W4200156908 creator A5070639714 @default.
• W4200156908 creator A5073765015 @default.
• W4200156908 creator A5077629563 @default.
• W4200156908 creator A5080623484 @default.
• W4200156908 date "2023-03-01" @default.
• W4200156908 modified "2023-10-18" @default.
• W4200156908 title "An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD" @default.
• W4200156908 cites W1889791828 @default.
• W4200156908 cites W1979423827 @default.
• W4200156908 cites W2006292992 @default.
• W4200156908 cites W2041479569 @default.
• W4200156908 cites W2059714773 @default.
• W4200156908 cites W2119605658 @default.
• W4200156908 cites W2125435699 @default.
• W4200156908 cites W2137591261 @default.
• W4200156908 cites W2163710303 @default.
• W4200156908 cites W2170892587 @default.
• W4200156908 cites W2180006680 @default.
• W4200156908 cites W2580009538 @default.
• W4200156908 cites W2594904924 @default.
• W4200156908 cites W2724740917 @default.
• W4200156908 cites W2734724639 @default.
• W4200156908 cites W2804456129 @default.
• W4200156908 cites W2805977157 @default.
• W4200156908 cites W2899595328 @default.
• W4200156908 cites W2930850699 @default.
• W4200156908 cites W3004467589 @default.
• W4200156908 cites W3004644667 @default.
• W4200156908 cites W3009392267 @default.
• W4200156908 cites W3011578493 @default.
• W4200156908 cites W3012883032 @default.
• W4200156908 cites W3015579983 @default.
• W4200156908 cites W3024628764 @default.
• W4200156908 cites W3031976336 @default.
• W4200156908 cites W3032413621 @default.
• W4200156908 cites W3034631925 @default.
• W4200156908 cites W3043179056 @default.
• W4200156908 cites W3048712397 @default.
• W4200156908 cites W3083923129 @default.
• W4200156908 cites W3089758949 @default.
• W4200156908 cites W3095202811 @default.
• W4200156908 cites W3111438304 @default.
• W4200156908 cites W3117083078 @default.
• W4200156908 cites W3118447624 @default.
• W4200156908 cites W3118615836 @default.
• W4200156908 cites W3122330053 @default.
• W4200156908 cites W3128683827 @default.
• W4200156908 cites W3132153535 @default.
• W4200156908 cites W3134080740 @default.
• W4200156908 cites W3143409077 @default.
• W4200156908 cites W3154897461 @default.
• W4200156908 cites W3159635575 @default.
• W4200156908 cites W3160190893 @default.
• W4200156908 cites W3163497914 @default.
• W4200156908 cites W3165273733 @default.
• W4200156908 cites W3167550451 @default.
• W4200156908 cites W3168108492 @default.
• W4200156908 cites W3172768534 @default.
• W4200156908 cites W3177624700 @default.
• W4200156908 cites W3183294941 @default.
• W4200156908 cites W3195179755 @default.
• W4200156908 cites W3196974118 @default.
• W4200156908 cites W3198902813 @default.
• W4200156908 cites W3201136001 @default.
• W4200156908 doi "https://doi.org/10.1016/j.cgh.2021.11.038" @default.
• W4200156908 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34871813" @default.
• W4200156908 hasPublicationYear "2023" @default.
• W4200156908 type Work @default.
• W4200156908 citedByCount "66" @default.
• W4200156908 countsByYear W42001569082021 @default.
• W4200156908 countsByYear W42001569082022 @default.
• W4200156908 countsByYear W42001569082023 @default.
• W4200156908 crossrefType "journal-article" @default.
• W4200156908 hasAuthorship W4200156908A5003334120 @default.
• W4200156908 hasAuthorship W4200156908A5004639766 @default.
• W4200156908 hasAuthorship W4200156908A5007912393 @default.
• W4200156908 hasAuthorship W4200156908A5009193858 @default.
• W4200156908 hasAuthorship W4200156908A5009462555 @default.
• W4200156908 hasAuthorship W4200156908A5015041967 @default.
• W4200156908 hasAuthorship W4200156908A5018422629 @default.
• W4200156908 hasAuthorship W4200156908A5023187572 @default.
• W4200156908 hasAuthorship W4200156908A5025459684 @default.
• W4200156908 hasAuthorship W4200156908A5033842737 @default.

• next